DDX5 promotes oncogene C3 and FABP1 expressions and drives intestinal inflammation and tumorigenesis
Sign Up to like & getrecommendations! Published in 2020 at "Life Science Alliance"
DOI: 10.26508/lsa.202000772
Abstract: In intestinal epithelial cells (IECs), DDX5 promotes the expression of immune response genes and oncogenes posttranscriptionally and is a novel therapeutic target for treating colitis and intestinal cancers. Tumorigenesis in different segments of the intestinal… read more here.
Keywords: promotes oncogene; oncogene fabp1; tumorigenesis; ddx5 promotes ... See more keywords